Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Comparing three single-use flexible ureteroscopes for treating kidney stones

Official title: A Comparative Study of Performance and Cost-effectiveness of Three Different Single-Use Flexible Ureteroscopes in the Management of Renal Stones: A Randomized Clinical Trial

Run by Ain Shams University · NCT07360353 · Data updated 2026-11-12

This compares three single-use flexible ureteroscopes to see which gives the best results for adults aged 18–60 with kidney stones smaller than 20 mm.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment180 (estimated)
SponsorAin Shams University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedJanuary 25, 2026
Main results expectedAugust 1, 2026
Study endsSeptember 1, 2026
Registry record updatedJanuary 27, 2026
Trial IDNCT07360353 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–60 with renal stones smaller than 20 mm who do not have active infection or major uncontrolled medical conditions are ideal candidates.

Probably not a fit

Patients with stones larger than 20 mm, active urinary tract infection, renal failure, pregnancy, uncontrolled comorbidities, abnormal urinary tract anatomy, or prior open ureteric surgery are unlikely to be eligible or to benefit from this device comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Retrograde intrarenal surgery (RIRS) with flexible ureteroscopy is the preferred treatment for renal stones under 20 mm, and this interventional study compares three single-use digital ureteroscope models (LithoVue, WiScope, and Scivita). Adult patients meeting inclusion criteria will undergo RIRS with one of the devices and investigators will record operative time, stone-free rate on follow-up imaging, postoperative complications, and device-related costs. Key eligibility criteria include age 18–60, renal stones <20 mm, and absence of active urinary infection or major uncontrolled comorbidities, with exclusions for pregnancy, renal failure, abnormal urinary anatomy, and prior open ureteric surgery. The trial is conducted at Ain Shams University Hospital in Cairo and focuses on practical performance and cost-effectiveness differences among available single-use devices.

Why it matters

Potential benefit: If one device proves superior or more cost-effective, patients could experience shorter procedures, fewer complications, and higher stone-free rates.

How similar studies have gone: Single-use ureteroscopes have been studied for safety and effectiveness, but direct head-to-head comparisons among multiple single-use models remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 18 to 60 years.
* Presence of renal stones measuring less than 20 millimeters (mm).

Exclusion Criteria:

* Renal stones larger than 20 millimeters (mm).
* Uncontrolled bleeding disorders or coagulopathies.
* Active urinary tract infection.
* Renal failure.
* Uncontrolled diabetes mellitus, hypertension, or hepatic dysfunction.
* Pregnancy.
* Abnormal urinary tract anatomy or known ureteric stricture.
* History of previous open ureteric surgery.

Where it's running

  • Ain Shams University hospital
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.